Almost $1 billion: F&P defies market chatter

Almost $1 billion: F&P defies market chatter
Managing director Lewis Gradon said the first half of the last financial year was a period of extraordinary demand during the initial surges of covid-19. (Image: supplied)
Staff reporters
Fisher & Paykel Healthcare has reported half-year revenue down just 1% to $900 million, defying analyst expectations of a significant sales slowdown. Investors have been waiting since August to get an update on how the company is tracking, with management unable to offer guidance due to unpredictable sales during the pandemic.Analysts from two of New Zealand’s largest broking firms predicted a revenue decline between 7% and 9% as covid-related sales normalised.Instead, the healthcare exporter’s revenue dropped just 1% in th...

More Markets

NZ stocks claw back lost ground to end up 0.8%
Markets Market Close

NZ stocks claw back lost ground to end up 0.8%

A gain in Ebos and expectations of lower interest rates have boosted NZ stocks.  

Jamie Gray 19 Sep 2025
FMA gets eligible investor certification clarity
Finance

FMA gets eligible investor certification clarity

High Court Justice Sally Fitzgerald released a 45-page judgment on Thursday.

Staff reporters 19 Sep 2025
Major stock moves expected as index reshuffles hit markets
Markets

Major stock moves expected as index reshuffles hit markets

Analysts are anticipating the week will end with significant volume and volatility.

Gregor Thompson 19 Sep 2025
Sharesies’ app affected by more than hour-long outage
Finance

Sharesies’ app affected by more than hour-long outage

Sharesies portfolio app was down for more than an hour, frustrating US-focused investors.

Andy Macdonald 19 Sep 2025